Proteolytic enzymes serve important functions during dental enamel formation, and mutations in the kallikrein 4 (KLK4) and enamelysin (MMP20) genes cause autosomal-recessive amelogenesis imperfecta (ARAI). So far, only 1 KLK4 and 3 MMP20 mutations have been reported in ARAI kindreds. To determine whether ARAI in a family with a hypomaturation-type enamel defect is caused by mutations in the genes encoding enamel proteolytic enzymes, we performed mutational analysis on candidate genes. Mutational and haplotype analyses revealed an ARAI-causing point mutation (c.910G>A, p.A304T) in exon 6 of MMP20 that results in a single amino acid substitution in the hemopexin domain. Western blot analysis showed decreased expression of the mutant protein, but zymogram analysis demonstrated that this mutant was a functional protein. The proband and an affected brother were homozygous for the mutation, and both unaffected parents were carriers. The enamel of newly erupted teeth had normal thickness, but was chalky white and became darker with age.
Get full access to this article
View all access options for this article.
References
1.
Bartlett JD, Beniash E, Lee DH, Smith CE (2004). Decreased mineral content in MMP-20 null mouse enamel is prominent during the maturation stage. J Dent Res83:909–913.
2.
Caterina JJ, Skobe Z, Shi J, Ding Y, Simmer JP, Birkedal-Hansen H, et al. (2002). Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem277:49598–49604.
3.
Fukae M, Tanabe T, Uchida T, Lee SK, Ryu OH, Murakami C, et al. (1998). Enamelysin (matrix metalloproteinase-20): localization in the developing tooth and effects of pH and calcium on amelogenin hydrolysis. J Dent Res77:1580–1588.
4.
Gomis-Ruth F (2004). Hemopexin domains. In: Handbook of metalloproteins. Vol. 3. Messerschmidt A, Bode W, Cygler M, editors. Chichester: John Wiley & Sons, Ltd, pp. 631–646.
5.
Hart PS, Hart TC, Michalec MD, Ryu OH, Simmons D, Hong S, et al. (2004). Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta. J Med Genet41:545–549.
6.
Hart PS, Becerik S, Cogulu D, Emingil G, Ozdemir-Ozenen D, Han ST, et al. (2009). Novel FAM83H mutations in Turkish families with autosomal dominant hypocalcified amelogenesis imperfecta. Clin Genet75:401–404.
7.
Iwata T, Yamakoshi Y, Hu JC, Ishikawa I, Bartlett JD, Krebsbach PH, et al. (2007). Processing of ameloblastin by MMP-20. J Dent Res86:153–157.
8.
Kida M, Sakiyama Y, Matsuda A, Takabayashi S, Ochi H, Sekiguchi H, et al. (2007). A novel missense mutation (p.P52R) in amelogenin gene causing X-linked amelogenesis imperfecta. J Dent Res86:69–72.
9.
Kim JW, Simmer JP, Hu YY, Lin BP-L,Boyd C, Wright JT, et al. (2004). Amelogenin p.M1T and p.W4S mutations underlying hypoplastic X-linked amelogenesis imperfecta. J Dent Res83:378–383.
10.
Kim JW, Seymen F, Lin BP, Kiziltan B, Gencay K, Simmer JP, et al. (2005a). ENAM mutations in autosomal-dominant amelogenesis imperfecta. J Dent Res84:278–282.
11.
Kim JW, Simmer JP, Hart TC, Hart PS, Ramaswami MD, Bartlett JD, et al. (2005b). MMP-20 mutation in autosomal recessive pigmented hypomaturation amelogenesis imperfecta. J Med Genet42:271–275.
12.
Kim JW, Lee SK, Lee ZH, Park JC, Lee KE, Lee MH, et al. (2008). FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta. Am J Hum Genet82:489–494.
13.
Lee SK, Hu JC, Bartlett JD, Lee KE, Lin BP, Simmer JP, et al. (2008). Mutational spectrum of FAM83H: the C-terminal portion is required for tooth enamel calcification. Hum Mutat29:E95–E99.
14.
Libson AM, Gittis AG, Collier IE, Marmer BL, Goldberg GI, Lattman EE (1995). Crystal structure of the haemopexin-like C-terminal domain of gelatinase A. Nat Struct Biol2:938–942.
15.
Overall CM, King AE, Bigg HF, McQuibban A, Atherstone J, Sam DK, et al. (1999). Identification of the TIMP-2 binding site on the gelatinase A hemopexin C-domain by site-directed mutagenesis and the yeast two-hybrid system. Ann NY Acad Sci878:747–753.
16.
Ozdemir D, Hart PS, Ryu OH, Choi SJ, Ozdemir-Karatas M, Firatli E, et al. (2005a). MMP20 active-site mutation in hypomaturation amelogenesis imperfecta. J Dent Res84:1031–1035.
17.
Ozdemir D, Hart PS, Firatli E, Aren G, Ryu OH, Hart TC (2005b). Phenotype of ENAM mutations is dosage-dependent. J Dent Res84:1036–1041.
18.
Papagerakis P, Lin HK, Lee KY, Hu Y, Simmer JP, Bartlett JD, et al. (2008). Premature stop codon in MMP20 causing amelogenesis imperfecta. J Dent Res87:56–59.
19.
Romisch K (2005). Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol21:435–456.
20.
Ryu OH, Fincham AG, Hu CC, Zhang C, Qian Q, Bartlett JD, et al. (1999). Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins. J Dent Res78:743–750.
21.
Van den Steen PE, Van Aelst I, Hvidberg V, Piccard H, Fiten P, Jacobsen C, et al. (2006). The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. J Biol Chem281:18626–18637.
22.
Wallon UM, Overall CM (1997). The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components. J Biol Chem272:7473–7481.
23.
Witkop CJ Jr (1988). Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J Oral Pathol17:547–553.
24.
Witkop CJ Jr, Sauk JJ Jr (1976). Heritable defects of enamel. In: Oral facial genetics. Stewart RE, Prescott GH, editors. St. Louis: C.V. Mosby Co., pp. 151–226.
25.
Yamada Y, Yamakoshi Y, Gerlach RF, Hu JC-C, Matsumoto K, Fukae M, et al. (2003). Purification and characterization of enamelysin from secretory stage pig enamel. Arch Comp Biol Tooth Enam8:21–25.
